Mesothelioma victims and their physicians in the near future have been given remarkable new hope for treatment, according to an innovative new study.
Orlando, FL (PRWEB) March 26, 2012
Mesothelioma victims and their physicians in the near future have been given remarkable new hope for treatment, according to an innovative new study. The study finding might give doctors early detection, greatly increasing survival rates.
Until recently, patients who suffered from mesothelioma were not diagnosed until their condition advanced. Therefore, their only option was to retain a mesothelioma attorney and file a lawsuit in order to cover medical costs. While there is not a known cure for the disease, early detection greatly extends life expectancy.
Early testing is key to survival and a revolutionary new breath test, which identifies trace amounts of exposure to asbestos to the onset of mesothelioma, can mean early diagnosis, giving the patient more treatment time.
Mesothelioma is the result of damaged pleural tissue, nearly exclusive to asbestos exposure. The disease is a rare cancer, affecting the lining of the victim’s abdomen and chest, usually concentrated in the lungs and heart.
Asbestos, widely used in the United States during the mid to late twentieth century, is a construction grade material. It was used in both construction and industrial applications because of its electrical and heat resistant properties. Unfortunately, because of its ubiquity, millions of Americans were exposed.
What’s more, patients often mistake early onset of mesothelioma for less severe conditions. This leads to missed diagnosis of the condition, shortening the time patients have to respond. Moreover, the disease can take as much as 20 to 50 years to manifest, greatly narrowing treatment options and survival rates.
To date, mesothelioma testing is done by thorascopic biopsy--a procedure in which physicians cut a small incision into the patient’s chest. A tube is then inserted to retrieve sample tissue. Because the procedure is so invasive, it carries significant risks such as hemorrhaging and possible collapsed lungs, especially in eldery patients.
But now, a breath test devised by Dutch researchers at the University of Amsterdam Medical Center could make thorascopic biopsy obsolete, according to a recently published study in the European medical journal, Lung Cancer.
The breath machine is designed to capture what is known as a “breathprint”, the organic compounds found in a patient’s breath. The study of 39 patients who either had asbestos exposure but no symptoms, patients who were completely healthy and patients diagnosed with mesothelioma. The testing was administered using a device known as “Cyranose 320”.
The device shows great promise in early trials, fully differentiating between patients diagnosed with mesothelioma and healthy patients 85 percent of the time and an impressive accuracy rating of 80 percent in discerning patients diagnosed with mesothelioma versus long term asbestos exposed patients.
For more information on the dangers of asbestos, the symptoms and treatment of mesothelioma and legal options of mesothelioma patients including how to file a mesothelioma lawsuit, visit MesoAuthority.com today.